Attitudes and Knowledge About Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Brazilian Infectious Disease Physicians

Imagem de Miniatura
Arquivos
art_CERQUEIRA_Attitudes_and_Knowledge_About_Human_Immunodeficiency_Virus_PreExposure_2020.PDF (167.97 KB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MARY ANN LIEBERT, INC
Autores
HOJILLA, J. Carlo
Citação
AIDS RESEARCH AND HUMAN RETROVIRUSES, v.36, n.12, p.1047-1053, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The objective was to describe levels and predictors of knowledge, attitudes, and willingness to prescribe pre-exposure prophylaxis (PrEP) among Brazilian Infectious Disease (ID) Physicians. The design was a cross-sectional study. We collected information on demographics and attitudes/knowledge about PrEP using an anonymous electronic survey. Willingness to prescribe PrEP, fear of adherence issues, and concerns about risk compensation were addressed in three case vignettes that varied by a single characteristic (i.e., by gender identity, drug use, and socioeconomic status) randomly assigned to physicians. Three hundred seventy ID physicians responded to the survey. Although most identified as informed/well informed about PrEP (75%) and believed PrEP availability to be necessary (38%), concerns with adherence (49%), side effects (38%), risk compensation (28%), and increase in sexually transmitted infection incidence (38%) were raised. We found no statistically significant differences in willingness to prescribe PrEP and concerns around risk compensation across the three case vignettes. ID physicians who declared having a religion reported more concerns about risk compensation compared to those self-identified as atheists (72% vs. 46%,p < .001). Most Brazilian ID physicians reported a positive attitude toward PrEP. Patients' gender identity, drug use, and socioeconomic status were not associated with willingness to prescribe PrEP. However, ID physicians who declared having a religion were more frequently concerned about risk compensation among PrEP users, suggesting that personal beliefs can influence PrEP implementation.
Palavras-chave
health knowledge, attitudes, practice, pre-exposure prophylaxis, implementation science, HIV infections
URI
https://observatorio.fm.usp.br/handle/OPI/39223
Referências
  1. Adams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595
  2. Blackstock OJ, 2017, J GEN INTERN MED, V32, P62, DOI 10.1007/s11606-016-3903-z
  3. Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z
  4. Calabrese SK, 2019, AIDS PATIENT CARE ST, V33, P79, DOI 10.1089/apc.2018.0166
  5. Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x
  6. Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295
  7. Desai M, 2016, HIV MED, V17, P133, DOI 10.1111/hiv.12285
  8. Goodman-Meza D, 2019, AIDS CARE, V31, P1228, DOI 10.1080/09540121.2019.1595523
  9. Grinsztejn B, 2018, LANCET HIV, V4, P1
  10. Grov C, 2019, AIDS BEHAV, V23, P1277, DOI 10.1007/s10461-018-2309-9
  11. Hojilla JC, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25103
  12. Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504
  13. Krakower D, 2012, CURR OPIN HIV AIDS, V7, P593, DOI 10.1097/COH.0b013e3283590446
  14. McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462
  15. Mimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289
  16. Ministerio da Saude: Secretaria de Vigilancia em Saude, 2018, B EP HIV AIDS 2018
  17. Ministerio da Saude: Secretaria de Vigilancia em Saude . Departamento de IST Aids e Hepatites Virais, 2017, PROT CLIN DIR TER PR
  18. Mullins TLK, 2017, AIDS PATIENT CARE ST, V31, P504, DOI 10.1089/apc.2017.0147
  19. Nunn AC, 2017, PLOS ONE, V12, pe0173057
  20. Page K, 2017, LANCET HIV, V4, pE52, DOI 10.1016/S2352-3018(16)30208-9
  21. Petroll AE, 2017, AIDS BEHAV, V21, P1256, DOI 10.1007/s10461-016-1625-1
  22. Petroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50f
  23. Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217
  24. Reyniers T, 2018, SEX HEALTH, V15, P606, DOI 10.1071/SH18072
  25. Seidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018
  26. Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283
  27. Silverman T, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10020166
  28. Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b
  29. UNAIDS, 2018, UNAIDS DAT 2018
  30. Varas-Diaz N., 2014, Journal of the International Association of Providers of AIDS Care, V13, P305, DOI 10.1177/2325957412472935
  31. Varas-Diaz N, 2010, GLOB PUBLIC HEALTH, V5, P295, DOI 10.1080/17441690903436581
  32. Westergaard RP, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-10
  33. Woolf-King SE, 2013, J URBAN HEALTH, V90, P948, DOI 10.1007/s11524-013-9820-0

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - LIM/60
Artigos e Materiais de Revistas Científicas - ODS/03